Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Psallidas, G. T. Stathopoulos, C. Moschos, A. Kollintza, S. Karabela, P. Theodoropoulou, S. A. Papiris, C. Roussos, I. Kalomenidis (Athens, Greece). Host-derived osteopontin is important for malignant pleural effusion formation. Eur Respir J 2008; 32: Suppl. 52, 391

Member's Comments

No comment yet.

Related content which might interest you: Osteopontin is important for malignant pleural effusion formation Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Talc mediates angiostasis in malignant pleural effusions via endostatin induction Source: Eur Respir J 2007; 29: 761-769 Year: 2007 Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 The value of IL6 in differentiation between malignant and non malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 The role of aquaporin-1 in the formation of pleural effusion Source: Eur Respir J 2005; 26: Suppl. 49, 553s Year: 2005 Osteopontin of either host or tumor origin critically affects malignant pleural effusion formation Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology Year: 2010 Non-classical monocytes potentiates the pathogenesis of malignant pleural effusion via the production of IL-1ß Source: International Congress 2019 – Biology of lung cancer Year: 2019 Malignant pleural effusion cells show aberrant glucose metabolism gene expression Source: Eur Respir J 2011; 37: 1453-1465 Year: 2011 C-reactive protein in differentiation between tuberculous and malignant pleural effusions Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion? Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 Is it important to determine pleural fluid amylase in patients with malignant pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007 Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding Year: 2019 Transudative malignant pleural effusions Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019 Mast cells recruitment to malignant pleural effusions Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Management of malignant pleural effusion Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001 A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma Source: Eur Respir J 2010; 36: 1099-1105 Year: 2010 The role of vascular endothelial growth factor in tuberculous and parapneumonic pleural effusions Source: Annual Congress 2008 - Pleural diseases and interventions Year: 2008 Pleurodesis for malignant pleural effusion Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016 Pleurodesis for malignant pleural effusion Source: School Course 2014 - Medical Thoracoscopy Year: 2014